Zobrazeno 1 - 10 of 352 pro vyhledávání: '"Schenkirsch G"'
1
Akademický článek
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany.
Autor: Krebs M; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany; Department of Urology and Pediatric Urology, University Hospital Würzburg, 97080 Würzburg, Germany. Electronic address: krebs_m@ukw.de., Haller F; Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, 91054 Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany., Spörl S; Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany; Department of Medicine V, Hematology and Oncology, University Hospital Erlangen, 91054 Erlangen, Germany., Gerhard-Hartmann E; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany; Institute of Pathology, University of Würzburg, 97080 Würzburg, Germany., Utpatel K; Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany., Maurus K; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany; Institute of Pathology, University of Würzburg, 97080 Würzburg, Germany., Kunzmann V; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany; Department of Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany., Chatterjee M; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany., Venkataramani V; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany., Maatouk I; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany; Department of Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany., Bittrich M; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany; Department of Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany., Einwag T; Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany., Meidenbauer N; Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany; Department of Medicine V, Hematology and Oncology, University Hospital Erlangen, 91054 Erlangen, Germany., Tögel L; Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, 91054 Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany., Hirsch D; Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany., Dietmaier W; Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany., Keil F; Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany., Scheiter A; Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany., Immel A; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany., Heudobler D; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053 Regensburg, Germany., Einhell S; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053 Regensburg, Germany., Kaiser U; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053 Regensburg, Germany., Sedlmeier AM; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053 Regensburg, Germany., Maurer J; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany., Schenkirsch G; Comprehensive Cancer Center Augsburg, 86156 Augsburg, Germany., Jordan F; Comprehensive Cancer Center Augsburg, 86156 Augsburg, Germany; Department of Hematology and Clinical Oncology, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany., Schmutz M; Comprehensive Cancer Center Augsburg, 86156 Augsburg, Germany; Department of Hematology and Clinical Oncology, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany; Institute of Digital Medicine (IDM), Medical Faculty, University of Augsburg, 86156 Augsburg, Germany., Dintner S; Comprehensive Cancer Center Augsburg, 86156 Augsburg, Germany; Institute of Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany., Rosenwald A; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany; Institute of Pathology, University of Würzburg, 97080 Würzburg, Germany., Hartmann A; Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, 91054 Erlangen, Germany; Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany., Evert M; Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany., Märkl B; Comprehensive Cancer Center Augsburg, 86156 Augsburg, Germany; Institute of Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany., Bargou R; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany; Bavarian Cancer Research Center (BZKF), 91052 Erlangen, Germany., Mackensen A; Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany; Department of Medicine V, Hematology and Oncology, University Hospital Erlangen, 91054 Erlangen, Germany; Bavarian Cancer Research Center (BZKF), 91052 Erlangen, Germany., Beckmann MW; Comprehensive Cancer Center Erlangen-EMN, 91054 Erlangen, Germany; Bavarian Cancer Research Center (BZKF), 91052 Erlangen, Germany; Department of Gynecology and Obstetrics, University Hospital Erlangen, 91054 Erlangen, Germany., Pukrop T; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053 Regensburg, Germany; Bavarian Cancer Research Center (BZKF), 91052 Erlangen, Germany; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053 Regensburg, Germany., Herr W; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053 Regensburg, Germany., Einsele H; Department of Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany; Bavarian Cancer Research Center (BZKF), 91052 Erlangen, Germany., Trepel M; Comprehensive Cancer Center Augsburg, 86156 Augsburg, Germany; Department of Hematology and Clinical Oncology, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany; Bavarian Cancer Research Center (BZKF), 91052 Erlangen, Germany., Goebeler ME; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany; Department of Internal Medicine II, University Hospital Würzburg, 97080 Würzburg, Germany., Claus R; Comprehensive Cancer Center Augsburg, 86156 Augsburg, Germany; Department of Hematology and Clinical Oncology, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany; Institute of Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, 86156 Augsburg, Germany., Kerscher A; Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, 97080 Würzburg, Germany., Lüke F; Comprehensive Cancer Center Ostbayern, 93053 Regensburg, Germany; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053 Regensburg, Germany; Division of Personalized Tumor Therapy, Fraunhofer Institute for Toxicology and Experimental Medicine, 93053 Regensburg, Germany.
Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Aug; Vol. 207, pp. 114144. Date of Electronic Publication: 2024 May 31.
Zobrazit plný text záznamu
2
Akademický článek
The Concept of Stroma AReactive Invasion Front Areas (SARIFA) as a new prognostic biomarker for lipid-driven cancers holds true in pancreatic ductal adenocarcinoma.
Autor: Grochowski P; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany. przemyslaw.grochowski@uk-augsburg.de., Grosser B; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Sommer F; General, Visceral and Transplantation Surgery, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Probst A; Gastroenterology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Waidhauser J; Hematology and Oncology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Schenkirsch G; Tumour Data Management, University Hospital Augsburg, Augsburg, Germany., Reitsam NG; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Märkl B; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Publikováno v: BMC cancer [BMC Cancer] 2024 Jun 26; Vol. 24 (1), pp. 768. Date of Electronic Publication: 2024 Jun 26.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
ALK, NUT, and TRK Do Not Play Relevant Roles in Gastric Cancer-Results of an Immunohistochemical Study in a Large Series.
Autor: Glückstein MI; General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, 86159 Augsburg, Germany., Dintner S; General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, 86159 Augsburg, Germany., Miller S; General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, 86159 Augsburg, Germany., Vlasenko D; General, Visceral, and Transplantation Surgery, Medical Faculty, University of Augsburg, 86159 Augsburg, Germany., Schenkirsch G; Tumor Data Management, Medical Faculty, University of Augsburg, 86159 Augsburg, Germany., Agaimy A; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, 91054 Erlangen, Germany., Märkl B; General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, 86159 Augsburg, Germany., Grosser B; General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, 86159 Augsburg, Germany.
Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2022 Feb 07; Vol. 12 (2). Date of Electronic Publication: 2022 Feb 07.
Zobrazit plný text záznamu
10
Akademický článek
Stroma AReactive Invasion Front Areas (SARIFA) - a new prognostic biomarker in gastric cancer related to tumor-promoting adipocytes.
Autor: Grosser B; General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany., Glückstein MI; General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany., Dhillon C; General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany., Schiele S; Institute of Mathematics and Computational Statistics, University of Augsburg, Augsburg, Germany., Dintner S; General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany., VanSchoiack A; NanoString Technologies, Inc, Seattle, WA, USA., Kroeppler D; NanoString Technologies, Inc, Seattle, WA, USA., Martin B; General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany., Probst A; Department of Gastroenterology, University Hospital Augsburg, Augsburg, Germany., Vlasenko D; General, Visceral and Transplantation Surgery, University Hospital of Augsburg, Augsburg, Germany., Schenkirsch G; Tumor Data Management, University Hospital Augsburg, Augsburg, Germany., Märkl B; General Pathology and Molecular Diagnostics, Medical Faculty, University of Augsburg, Augsburg, Germany.
Publikováno v: The Journal of pathology [J Pathol] 2022 Jan; Vol. 256 (1), pp. 71-82. Date of Electronic Publication: 2021 Oct 22.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje